Differential grey matter structure in women with premenstrual dysphoric disorder: evidence from brain morphometry and data-driven classification
Dubol M, Stiernman L, Wikström J, Lanzenberger R, Epperson CN, Sundström Poromaa I, Bixo M, Comasco E
Translation Psychiatry 2022 In press

Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
Comasco E, Kopp Kallner H, Bixo M, Hirschberg AL, Nyback S, de Grauw H, Epperson CN, Sundström-Poromaa I.
Am J Psychiatry. 2021 Mar 1;178(3):256-265

Evidence for a Link Between Fkbp5/FKBP5, Early Life Social Relations and Alcohol Drinking in Young Adult Rats and Humans.
Nylander I, Todkar A, Granholm L, Vrettou M, Bendre M, Boon W, Andershed H, Tuvblad C, Nilsson KW, Comasco E.
Molecular Neurobiology. 2017 Oct;54(8):6225-6234.

Supraphysiological Hormonal Status, Anxiety Disorders, and COMT Val/Val Genotype are Associated with Reduced Sensorimotor Gating in Women.
Comasco E, Hellgren C, Olivier J, Skalkidou A, Sundström Poromaa I.
Psychoneuroendocrinology. 2015 Oct; 60:217-23.

Emotional Fronto-Cingulate Cortex Activation and Brain Derived Neurotrophic Factor Polymorphism in Premenstrual Dysphoric Disorder.
Comasco E, Hahn A, Ganger S, Gingnell M, Bannbers E, Oreland L, Wikström J, Epperson CN, Lanzenberger R, Sundström-Poromaa I.
Human Brain Mapping. 2014 Sep;35(9):4450-8.

View more here: https://www.ncbi.nlm.nih.gov/pubmed/?term=comasco+e